Pharmaceutical Combination comprising a beta blocker and an inhibitor of HMG CoA reductase Inhibitors, Pharmaceutical formulation, transportable Equipment Parts, use of this Combination and this Formulation for preparing medicines

摘要

Una combinacion farmac utica que comprende una beta bloqueante y un inhibidor de la HMG-CoA reductasa donde el beta bloqueante se selecciona del grupo consistente en acebutolol alprenolol amosulalol arotinolol atenolol befunolol betaxolol bevantolol bisoprolol bopindolol bucumolol bufetolol bufuralol bunitrolol buprandolol butofilolol carazolol carteolol carvedilol celiprolol cetamolol cloranolol The HMG CoA inhibitors to be reduced were selected from the following groups: cerivastatina, itavastatina, lovastatina, mevastatina, Nico tatina, as well as salts or solutions acceptable on the drug; and HMG CoA inhibitors to be reduced. 1. Niwastina and acid (E) - 7 [4 - (4-fluorophenyl) - 6-isopropyl-2 - [methylenethio) amine] - pirimidin-5-il] (3R. 5S) - 3, 5-dihydroxy-6-phenol or an acceptable salt or drug solution, or a salt solution thereof, which is a preventive or therapeutic use for polymers, high cholesterol and high fat; Pharmaceutical plants, transportable parts,I use this combination and this recipe to prepare the medicine